GZMB and COVID-19: Moreover, the SARS-CoV-2 response in uninfected controls was characterized by significantly elevated expression of GrB compared with COVID-19 cases (median: 30.6%, IQR: 5%–64.2% vs. 4.4%, IQR: 1.9%–9.6%, respectively, P = 0.001).